AGY Therapeutics Turns to Cengent for X-Ray Crystallography

genomeweb
360dx

AGY Therapeutics Turns to Cengent for X-Ray Crystallography

Jun 30, 2003

NEW YORK, June 30 - Cengent Therapeutics, formed by the merger in May of Structural Bioinformatics and GeneFormatics, said today that it has signed an agreement with AGY Therapeutics for its X-ray crystallography services.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Quadrant Biosciences Wins $2M NIH Grant for Autism Test
Cepheid Fingerstick HCV Test Receives CE-IVD Clearance
Fleury Group to License IDbyDNA NGS Platform
Long Noncoding RNAs Classified Based on Sequence Motifs
Prescient Medicine, Metabiomics Form GI Dx Partnership
Genomic Analysis of Present-Day Sardinians Shows Significant Influence From Neolithic Sources

The Scan

NIH's Collins on Harassment

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

With Eight Arms and Giant Eyes

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Missing From Trials

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

This Week in Cell

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.

Main menu